US Archives - Page 63 of 148 - European Medical Journal

Lipid-Rich Emulsion Outperforms Standard Cream in Eczema Study

A new dermatology study offers compelling evidence that targeted lipid supplementation can restore the skin barrier in adults with a history of atopic dermatitis, outperforming commonly used emollients.

Pediatric Acute Respiratory Infections Risks in Mexico Investigated

A cross-sectional study conducted at the Hospital Infantil de México “Federico Gómez” has shed new light on the demographic and clinical factors driving pediatric respiratory infections in Latin America.

Early Heart Risks After Stem Cell Transplant Revealed

A new study sheds light on the hidden cardiovascular risks lurking in the critical first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).

Can AI Predict Stroke Complications Before They Strike?

In a breakthrough meta-analysis designed for clinicians and healthcare professionals, machine learning tools have shown promising accuracy in predicting hemorrhagic transformation (HT) in patients with acute ischemic stroke (AIS).

Phase III Trial Results: Nerandomilast in Pulmonary Fibrosis

In a Phase III clinical trial, nerandomilast, an oral phosphodiesterase 4B inhibitor, was associated with a smaller decline in lung function over 52 weeks in patients with progressive pulmonary fibrosis, when compared with placebo.

Invasive Candidiasis Management Gaps in ICUs Shared in 2024 Survey

Invasive candidiasis remains a significant challenge for intensive care units worldwide due to its high mortality rate, diagnostic complexity, and increasing resistance.

Osteoarthritis Surgery Reviewed: Risks, Results, and Recommendations

Surgical intervention for severe osteoarthritis continues to be a critical decision point in orthopedics.

Sexual Behavior Strongest Driver of Gut Microbiome in HIV

In a new study that challenges conventional assumptions about gut health in people living with HIV, researchers have found that sexual behavior has a stronger association with gut microbiome composition than either antiretroviral therapy (ART) regimens or weight changes.

Precision Approaches in Colorectal Cancer: Interview with John Strickler

It has been known for years that there is a small subgroup of patients with colorectal cancer who have HER2-positive disease…

The Evolving Standard of Care in Advanced Biliary Tract Cancers

This infographic presents three-year follow-up data from the TOPAZ-1 trial; the first global Phase III study to evaluate an immuno…